BioNTech SE (BNTX) EBT Margin (2018 - 2026)
BioNTech SE (BNTX) reported EBT Margin of 17.22% for Q3 2026, up 15.59 percentage points from 1.63% a year earlier and up 830.38 percentage points from the prior quarter.
Powered by 
Analysis
BioNTech SE (BNTX) EBT Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, BioNTech SE's EBT Margin came in at -59.72%, down 43.50 percentage points year-over-year; for FY2025, it came in at -36.61%, down 11.98 percentage points from FY2024.
- EBT Margin has declined for four consecutive years, with a five-year change of -6.38 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -24.63% in FY2024 (-55.69 pp), 31.06% in FY2023 (-43.78 pp), 74.83% in FY2022 (-4.46 pp) and 79.29% in FY2021 (+109.52 pp).
- The Q3 2026 figure ranks as the highest quarterly EBT Margin since Q4 2024.
- Year over year, EBT Margin gained in two of the last eight quarters, with an average year-over-year change of -69.58 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2025 (a gain of 471.70 percentage points); the low point was Q2 2026 (a drop of 658.75 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at -813.16% (Q2 2026), -481.03% (Q1 2026) and -25.06% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | BioNTech SE | 21.19 Bn | -49.68 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 17.22% |
| Jun 30, 2026 | -813.16% |
| Mar 31, 2026 | -481.03% |
| Dec 31, 2025 | -25.06% |
| Sep 30, 2025 | 1.63% |
| Jun 30, 2025 | -154.41% |
| Mar 31, 2025 | -243.65% |
| Dec 31, 2024 | 25.31% |
| Sep 30, 2024 | 12.75% |
| Jun 30, 2024 | -626.11% |
| Mar 31, 2024 | -176.87% |
| Dec 31, 2023 | 44.84% |
| Sep 30, 2023 | 25.40% |
| Jun 30, 2023 | -245.80% |
| Mar 31, 2023 | 55.42% |
| Dec 31, 2022 | 74.16% |
| Sep 30, 2022 | 70.61% |
| Jun 30, 2022 | 72.56% |
| Mar 31, 2022 | 78.72% |
| Dec 31, 2021 | 85.20% |
API Access
BioNTech SE EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();